Journey Medical Corp. (DERM)
5.985
-0.14
(-2.21%)
USD |
NASDAQ |
May 27, 16:00
5.985
0.00 (0.00%)
After-Hours: 17:39
Journey Medical Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 15.11M |
| Fortress Biotech, Inc. | 0.00 |
| Zevra Therapeutics, Inc. | 79.62M |
| Aquestive Therapeutics, Inc. | -0.052M |
| Corcept Therapeutics, Inc. | 4.542M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.909M |
| Cash from Financing (Quarterly) | 0.22M |
| Free Cash Flow | -6.775M |
| Free Cash Flow Per Share (Quarterly) | 0.1065 |
| Free Cash Flow to Equity (Quarterly) | 2.838M |
| Free Cash Flow to Firm (Quarterly) | 3.801M |
| Free Cash Flow Yield | -4.41% |